Biologic Outsourcing STREAM

  1. Integrated Technologies And Glycosylation Tuning In Upstream Bioprocessing 7/1/2025

    Optimize mAb production with innovative cell culture media and feed designs. Explore integrated technologies, intensified fed-batch approaches, and methods to modulate glycosylation profiles in upstream bioprocessing.

  2. Providing Value Optimized, Time Saving Oligo Solutions 12/16/2021

    Whether you are in the beginning research stages or ready to take your product to market, our scalable, high quality, and custom oligo and peptide solutions provide the quantities you need using the most reliable, robust, and cost-effective process available.

  3. OPTIMA 7000 Fill Line 6/7/2021

    Ajinomoto Bio-Pharma Services is a leader in aseptic filling, offering a wide range of capabilities for vials with our OPTIMA 7000 fill line. The OPTIMA VFVM 7000 safely processes various types and classes of biopharmaceutical products in 2 mL to 100 mL sizes.

  4. Targeting The Fast Lane With Optimized Viral Detection 4/6/2023

    Discover a groundbreaking method that allows you to accelerate viral detection by combining the broad range of NGS with the sensitivity of PCR.

  5. Rising To Meet Increasing Demand For Microbial Based Biologics 12/16/2021

    The production of your biotherapeutic deserves the reliability and peace of mind that only a trusted and experienced microbial fermentation partner can provide. Ajinomoto Bio-Pharma Services is a recognized leader in recombinant protein, plasmid DNA, and critical raw material manufacturing for vaccine and gene therapy applications.

  6. 60-Seconds Of Science: Optimizing Complex Molecule Production 2/20/2026

    A principal scientist shares how his team overcame key manufacturing challenges in complex bispecific antibody production, highlighting problem-solving strategies and impressive results in this concise educational video.

  7. Your Digital QC Companion For Sterility Testing 8/13/2024

    Discover software designed to ensure fully accurate data recording in sterility testing and that complies with 21 CFR Part 11 standards for electronic records and signatures.

  8. New Approaches To Tailored Release Profiles 7/7/2025

    Tailored drug release is evolving from formulation tactic to precision therapy strategy, optimizing timing, site, and rate of delivery for improved patient outcomes.

  9. Abzena Capacity Update October 2025: Large Molecule 10/16/2025

    Accelerate your therapeutic antibody and complex protein development with advanced mammalian cell line platforms that move from DNA to RCB in just 10 weeks.